MAIA Biotechnology
MAIA
MAIA
20 hedge funds and large institutions have $1.5M invested in MAIA Biotechnology in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
-2
Holders Change %
-9.09%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$237K |
| 2 |
VF
Virtu Financial
New York
|
+$71K |
| 3 |
Jane Street
New York
|
+$55.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$19.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.56K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$204K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$153K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$74.2K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$66K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$28K |
